Press release
Compounding Chemotherapy Market to Reach USD 1.65 Billion by 2034
Compounding Chemotherapy
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/50043
Key Takeaways
• Market Size (2024): USD 1.1 Billion
• Forecast (2034): USD 1.65 Billion
• CAGR (2025 - 2034): 4.2 %
• Leading Companies: Baxter International Inc., B. Braun Melsungen AG, ICU Medical Inc., Fresenius Kabi AG, Omnicell Inc., Grifols S.A., Capsa Healthcare, ARxIUM Inc., Equashield LLC, and Terumo Corporation.
• Core Segments: Cytotoxic Drug Compounding | Non-Cytotoxic Antineoplastic Preparations | Aseptic Automation | Pharmacy Clean-Room Infrastructure.
Market Story
With cancer cases rising globally, hospitals and oncology centers are increasing investment in safe and efficient sterile-compounding environments. Automated compounding robots, dose-tracking software, and closed-system transfer devices (CSTDs) are becoming standard to minimize occupational exposure and ensure precision dosing.
Demand for individualized chemotherapy admixtures-tailored to patient body surface area, toxicity profile, and treatment regimen-is also expanding, particularly across North America and Europe. Meanwhile, developing regions are adopting outsourced oncology compounding services to manage growing patient volumes while meeting stringent regulatory standards.
Market Segmentation
• By Type: Cytotoxic Compounding | Non-Cytotoxic Compounding | Nutritional Support Admixtures | Others
• By End User: Hospital Pharmacies | Oncology Centers | Outsourced Compounding Facilities | Academic Research Institutions
• By Technology: Manual Compounding | Semi-Automated Systems | Fully Automated Robotic Compounding
• By Region:
o North America: Largest market driven by USP / compliance and CSTD integration.
o Europe: Rapid adoption of robotic pharmacy solutions for hazardous drug handling.
o Asia Pacific: Fastest growth due to rising cancer burden and expanding oncology infrastructure in India and China.
o Latin America & MEA: Increasing outsourcing of sterile drug compounding and government investments in hospital modernization.
Explore Full Report here: https://exactitudeconsultancy.com/reports/50043/compounding-chemotherapy-market
Recent Developments
• 2025: Baxter introduced a robotic drug-compounding system to enhance sterility and reduce waste in hospital pharmacies.
• 2024: B. Braun launched its ClinMix Pro solution integrating AI-based dose verification for cytotoxic agents.
• 2023: ICU Medical expanded its ChemoLock portfolio to meet ISO standards for closed drug transfer systems.
• 2022: Omnicell acquired ARxIUM to enhance its automation capabilities in oncology compounding.
Expert Quote
"Automation and precision have become the cornerstones of modern chemotherapy compounding. As oncology care moves toward personalized dosing and safer handling, pharmacies must integrate data-driven systems that ensure accuracy and compliance," said Irfan Tamboli, Business Development Executive at Exactitude Consultancy.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=50043
Market Drivers
1. Rising Global Cancer Prevalence and Complex Chemotherapy Regimens.
2. Increased Adoption of Robotic and CSTD Technologies.
3. Regulatory Focus on USP / Sterile Standards and Occupational Safety.
4. Growing Demand for Personalized Medication Preparation in Oncology.
Forecast Outlook
Between 2025 and 2034, the industry will see a surge in AI-enabled dose validation, data integration with EHR systems, and modular clean-room facilities. Service providers offering end-to-end automation and regulatory support will dominate future contract compounding landscapes.
Conclusion
The Compounding Chemotherapy Market is poised for steady expansion as healthcare systems prioritize precision, safety, and automation. With continued technological innovation and regulatory alignment, the sector will play a critical role in advancing safe and personalized oncology care worldwide.
This report is also available in the following languages : Japanese (複合化学療法市場), Korean (복합 화학 요법 시장), Chinese (复合化疗市场), French (Marché de la chimiothérapie composée), German (Markt für die Herstellung von Chemotherapie-Mischungen), and Italian (Mercato della chemioterapia composta), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/50043/compounding-chemotherapy-market#request-a-sample
Related Reports
Peritoneal Carcinomatosis (PC) Market
https://exactitudeconsultancy.com/reports/71611/peritoneal-carcinomatosis-pc-market
Head and neck squamous cell carcinomas (HNSCCs) Patient Pool Market
https://exactitudeconsultancy.com/reports/71640/head-and-neck-squamous-cell-carcinomas-hnsccs-patient-pool-market
Epstein-Barr Virus-associated Post-Transplant Lymphoproliferative Disease Market
https://exactitudeconsultancy.com/reports/71962/epstein-barr-virus-associated-post-transplant-lymphoproliferative-disease-market
Chemotherapy-induced Nausea and Vomiting Market
https://exactitudeconsultancy.com/reports/72895/chemotherapy-induced-nausea-and-vomiting-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Compounding Chemotherapy Market to Reach USD 1.65 Billion by 2034 here
News-ID: 4266746 • Views: …
More Releases from Exactitude Consultancy
Natural Killer (NK) Cell Therapies Market with CAGR 19.3% 2025-2034
The Global Natural Killer (NK) Cell Therapies Market is rapidly evolving due to rising clinical success of NK cell-based immunotherapies, strong investment in oncology drug development, and high demand for effective treatments against hematologic and solid tumors. NK cell therapies offer significant advantages-including innate tumor-killing ability, lower risk of graft-versus-host disease, and enhanced safety profiles compared to CAR-T therapies.
Market Size & Growth Outlook
• Market Value (2024): USD 2.1 Billion
• Forecast Value (2034):…
Vaccine Contract Manufacturing Market Trades ,Demands 2034
The Global Vaccine Contract Manufacturing Market is experiencing strong momentum as pharmaceutical and biotechnology companies increasingly outsource vaccine production, fill-finish operations, and large-scale formulation to specialized CDMOs. The need for faster commercialization, cost optimization, and advanced biologics manufacturing capabilities-especially after the COVID-19 era-has accelerated the demand for high-quality contract manufacturing services worldwide.
Market Size & Growth Outlook
• Market Value (2024): USD 4.8 Billion
• Forecast Value (2034): USD 12.9 Billion
• CAGR (2025-2034): 10.4%
The market will…
Mitochondrial Disease Therapies Market Demand 2034
Market Overview
The Mitochondrial Disease Therapies Market is experiencing strong growth as awareness, diagnosis rates, and clinical research activity surrounding rare mitochondrial disorders increase worldwide. Mitochondrial diseases, often caused by inherited or spontaneous mutations affecting cellular energy production, currently have limited approved treatments, driving significant unmet medical need and investment in novel therapeutics.
The market is projected to expand steadily through 2024-2034, supported by gene therapy advancements, targeted drug development, and improved…
Antibody-Drug Conjugate (ADC) Market to Surpass USD 30 Billion by 2034 as Oncolo …
The Antibody-Drug Conjugate (ADC) Market is experiencing explosive growth as ADCs become one of the fastest-expanding segments in oncology therapeutics. With more than a dozen commercialized ADC drugs and hundreds of candidates in development, pharmaceutical companies are investing aggressively in targeted cancer therapies that deliver high efficacy with reduced systemic toxicity.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73125
What Are Antibody-Drug Conjugates (ADCs)?
ADCs are targeted cancer therapies that combine:
• A monoclonal…
More Releases for Compounding
Compounding Pharmacies Business Development Strategies for Expanding Your Market …
The global compounding pharmacies market size was US$ 8.1 billion in 2021. The global compounding pharmacies market size is estimated to reach US$ 13.9 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2022 to 2030.
Request To Download Sample of This Strategic Report :-https://reportocean.com/industry-verticals/sample-request?report_id=bwcc17220
A compounding pharmacy is a distinctive kind of pharmacy. They can create customized medicines for the individual who…
NBR Compounding Market Report Status And Outlook 2022-2027-Hexpol Compounding, P …
The NBR Compounding Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. We analyzed the impact of…
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global…
U.S. Compounding Pharmacies Market Global Key Players - Premier Pharmacy Labs, R …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market ; Eminent Players - Pencol Compounding Pharma …
Endowed with numerous regulatory compliances, the U.S. compounding pharmacies market has been traversing toward becoming one of the most profitable business spaces. Owing to the lack of safety and absence of clinical clearances, compounded medications have been under stringent scrutiny that has been helping players in the U.S. compounding pharmacies to strengthen their existing manufacturing practices. The surging use of compounded medicines for pain relief and hormone replacement therapies is…
U.S. Compounding Pharmacies Market Key Players – McKesson Corporation, Nephron …
U.S. Compounding Pharmacies Market size is set to exceed USD 7 billion by 2025; according to a new research report by Global Market Insights, Inc.
Growing prevalence of chronic diseases in the U.S. such as cancer, diabetes, cardiovascular disease, respiratory diseases and obesity will drive the U.S. compounding pharmacies market growth over the forecast period. Increasing drug shortage in the country due to production delays and unavailability of previously manufactured…
